These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 34198889)
1. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. Kabzinski J; Maczynska M; Majsterek I Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198889 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma. Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115 [TBL] [Abstract][Full Text] [Related]
3. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma. Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216 [TBL] [Abstract][Full Text] [Related]
4. Circulating small non-coding RNA signature in head and neck squamous cell carcinoma. Victoria Martinez B; Dhahbi JM; Nunez Lopez YO; Lamperska K; Golusinski P; Luczewski L; Kolenda T; Atamna H; Spindler SR; Golusinski W; Masternak MM Oncotarget; 2015 Aug; 6(22):19246-63. PubMed ID: 26057471 [TBL] [Abstract][Full Text] [Related]
5. Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer. Subha ST; Chin JW; Cheah YK; Mohtarrudin N; Saidi HI Mol Biol Rep; 2022 Feb; 49(2):1501-1511. PubMed ID: 34837627 [TBL] [Abstract][Full Text] [Related]
6. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma. Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417 [TBL] [Abstract][Full Text] [Related]
7. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638 [TBL] [Abstract][Full Text] [Related]
9. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells. Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038 [TBL] [Abstract][Full Text] [Related]
10. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
12. Role of miRNA in head and neck squamous cell carcinoma. Masood Y; Kqueen CY; Rajadurai P Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254 [TBL] [Abstract][Full Text] [Related]
13. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621 [TBL] [Abstract][Full Text] [Related]
14. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma. Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4. Hersi HM; Raulf N; Gaken J; Folarin N; Tavassoli M Mol Oncol; 2018 Dec; 12(12):2023-2041. PubMed ID: 29959873 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA alterations in head and neck squamous cell carcinoma. Chang SS; Jiang WW; Smith I; Poeta LM; Begum S; Glazer C; Shan S; Westra W; Sidransky D; Califano JA Int J Cancer; 2008 Dec; 123(12):2791-7. PubMed ID: 18798260 [TBL] [Abstract][Full Text] [Related]
18. [The Role of microRNA in head and neck cancer focusing on sinonasal carcinoma]. Kovaříková H; Chmelařová M; Palička V Cas Lek Cesk; 2016; 155(2):45-50. PubMed ID: 27088793 [TBL] [Abstract][Full Text] [Related]
19. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma. Shi H; Chen J; Li Y; Li G; Zhong R; Du D; Meng R; Kong W; Lu M Oncotarget; 2016 Apr; 7(16):21579-90. PubMed ID: 26933913 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma. Nohata N; Hanazawa T; Kinoshita T; Okamoto Y; Seki N Auris Nasus Larynx; 2013 Apr; 40(2):143-9. PubMed ID: 22831895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]